CD79A and schizophrenia: The aim of this study was to determine the differences in the concentrations of markers related to IgG and IgA sensitivity, inflammation and gut integrity between the first episode of schizophrenia (FS), chronic schizophrenia (CS) patients, and healthy individuals (HC), and to establish potential connections between inflammation, gluten sensitivity and intestinal permeability.